Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antiarrhythmic drugs.

M M Scheinman, D S Hess

    American Journal of Surgery
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    New antiarrhythmic drugs offer improved cardiac arrhythmia treatment. Advances include Type I drugs for premature ventricular contractions and calcium antagonists for supraventricular arrhythmias, alongside selective beta-blockers and amiodarone.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Brugada syndrome.

    Proceedings (Baylor University. Medical Center)·2005
    Same author

    Clinical cardiac electrophysiology fellowship teaching objectives for the new millennium.

    Journal of cardiovascular electrophysiology·2002
    Same author

    Electrophysiological effects of ibutilide in patients with accessory pathways.

    Circulation·2001
    Same author

    NASPE Plenary Lecture 2001. Catheter ablation: a personal perspective.

    Journal of cardiovascular electrophysiology·2001
    Same author

    Relationship between sinus rhythm activation and the reentrant ventricular tachycardia isthmus.

    Circulation·2001
    Same author

    Atypical right atrial flutter patterns.

    Circulation·2001
    Same journal

    High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

    American journal of surgery·2026
    Same journal

    Women with firearm injuries: A multicenter mixed-methods study.

    American journal of surgery·2026
    Same journal

    SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

    American journal of surgery·2026
    Same journal

    Using Dr. Google and AI to stay informed.

    American journal of surgery·2026
    Same journal

    Revealing the sex divide: Primary hyperparathyroidism across the American population.

    American journal of surgery·2026
    Same journal

    Pressure points: A pilot study using the NASA-TLX tool to measure the intensity of Acute care surgery work.

    American journal of surgery·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology
    • Electrophysiology

    Background:

    • Significant progress in understanding cardiac arrhythmias and antiarrhythmic drug effects.
    • Introduction of novel antiarrhythmic agents with distinct mechanisms of action.

    Purpose of the Study:

    • To review recent advancements in antiarrhythmic drug therapy.
    • To highlight the efficacy and limitations of new drug classes.

    Main Methods:

    • Review of new antiarrhythmic drug classes including Type I agents, calcium antagonists, beta-blockers, and amiodarone.
    • Discussion of their cellular electrophysiologic effects and clinical applications.

    Main Results:

    • Type I drugs (encainide, flecainide, lorcainide) effectively suppress premature ventricular contractions by depressing cardiac conduction.

    Related Experiment Videos

  • Verapamil (calcium antagonist) rapidly controls supraventricular arrhythmias via slow-channel blockade.
  • Selective beta1-blockers offer targeted cardiac receptor blockade.
  • Amiodarone is potent for both supraventricular and ventricular arrhythmias, prolonging action potential duration.

    • Conclusions:

    • New antiarrhythmic drugs provide diverse therapeutic options for managing cardiac arrhythmias.
    • While effective, some drugs like amiodarone present significant long-term side effect profiles (e.g., pulmonary fibrosis, thyroid dysfunction).